Latham BioPharm Group Awarded NIAID Preclinical Services IDIQ Contract Valued at Up to $30 Million
Latham BioPharm Group, part of SIA Partners, today announced receiving a new Indefinite Delivery, Indefinite Quantity (IDIQ) contract award from the National Institute of Allergy and...
AnaBios Boosts Discovery of Safer, More Effective Medicines With License From the University of Louisville
The agreement will drive the discovery of more effective treatments for cardiovascular disease and development of safer drugs with the preclinical implementation of advanced human...